DIA
WST icon

Dana Investment Advisors’s West Pharmaceutical WST Stock Holding History

Dana Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-25,337
Closed -$1.35M – 287
2014
Q4 		$1.35M Buy
25,337
+1,316
+5% +$65.8K 0.05% 144
2014
Q3 		$1.07M Buy
24,021
+11,256
+88% +$478K 0.06% 155
2014
Q2 		$538K Buy
12,765
+7,235
+131% +$310K 0.03% 219
2014
Q1 		$244K Buy
5,530
+1,083
+24% +$51K 0.02% 254
2013
Q4 		$218K Buy
+4,447
New +$208K 0.01% 263

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dana Investment Advisors's WST Position: Q1 2015 in Review

Dana Investment Advisors sold out of West Pharmaceutical (WST) in Q1 2015, closing a stake of 25,337 shares — an estimated $1.35M sold.

Dana Investment Advisors first reported a position in WST in Q4 2013 and held it in 5 quarters. The position peaked at $1.35M in Q4 2014. 214 funds tracked by Wall St. Rank hold WST as of Q1 2015.

  • Dana Investment Advisors reported no remaining West Pharmaceutical position as of Q1 2015 after selling out during the quarter.
  • Dana Investment Advisors sold 25,337 West Pharmaceutical shares in Q1 2015, an estimated $1.35M.
  • Dana Investment Advisors first reported a position in West Pharmaceutical in Q4 2013 and held it in 5 quarters.
  • Dana Investment Advisors's West Pharmaceutical position peaked at $1.35M in Q4 2014.
  • 214 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2015.

Based on Dana Investment Advisors's 13F filing for Q1 2015, filed 15 May 2015.